Aptar CSP Technologies’ Activ-Blister™ Solutions Now Available for Manufacturing in the EMEA Region

Aptar CSP Technologies, part of AptarGroup, Inc. and a leader in active material science solutions to ensure product protection, extend shelf life and improve patient experience, announces a new manufacturing site able to produce its Activ-Blister™ Solutions for oral slide dose drugs in Europe. The move is part of a key strategic effort to expand production of Activ-Blister™ technology globally and is the result of a 3-way collaboration between Aptar CSP, Uhlmann (a leading pharmaceutical packaging equipment manufacturer), and Ivers-Lee, www.iverslee.com, (a local contract manufacturing organization).

This collaboration consists of a fully automated Uhlmann blister machine validated to package oral solid dose drug products with Activ-Blister™ Solutions heat-staked to the foil at a rate of up to 250 blisters per minute (Figure 1). The equipment is designed to integrate Activ-Blister™ technology into the blister cavity with precision placement (Figure 2). The equipment has been fully-validated and is in place at Ivers-Lee, a CMO capable of manufacturing Activ-Blister™ solutions from R&D to commercialization. A CMO in EMEA will support regional customers and ensure speed-to-market.

“Expanding global manufacturing sites for Activ-Blister™ technology reflects our commitment to delivering global access to innovative active material science solutions for patients and consumers,” said Badre Hammond, VP Commercial Operations and GM APAC, Aptar CSP Technologies. “With manufacturing capabilities now available in both the US and EMEA, we will turn our attention to bringing production of this technology to the Asia market.”

Activ-Blister™ Solutions integrates Aptar CSP’s proprietary 3-Phase Activ-Polymer™ platform technology into individual blister cavities to provide precision microclimate protection for sensitive drug products. This technology can be customized specifically for the drug developer’s formulation to provide a broad spectrum of specific drug protection including moisture adsorption, and oxygen and odor scavenging. The technology can also scavenge volatile organic compounds (VOCs) and emit aromas.
https://www.aptar.com/news-events/aptar-csp-activ-blister-solutions-now-manufactured-in-emea/

Related Posts

Stora Enso invests EUR 80 million in wood handling at Imatra mills

Stora Enso has decided to invest in centralising and modernising the wood handling capacity at its Imatra mills in Finland. The investment of EUR 80 million will enhance Stora Enso’s production capabilities for premium packaging board. The investment supports the Group’s strategy of sustainable profitable growth through packaging in strong customer segments. The investment is planned to start in Q1 2021 and to be completed in Q3 2022. The Imatra mills produce premium packaging boards for food, beverage and luxury packaging. The purpose of the investment is to modernise the wood handling process in Imatra and centralise it in one of the existing wood yards. The project includes the installation of a new, third debarking line, improvements to chip handling systems, and modifications to the existing wood yard infrastructure. The centralised and modernised wood handling capacity will improve the stability and efficiency of the process. In addition, the new, more efficient debarking line will reduce water consumption of the process and lower the environmental impact.

American Forest & Paper Association Releases April 2021 Packaging Papers Monthly Report

Total packaging papers & specialty packaging shipments in April increased four percent compared to April 2020. They were up one percent when compared to the same four months of 2020. The operating rate was 95.1 percent, up 9.6 points from April 2020 and up 5.2 points year-to-date. Mill inventories at the end of April increased 9,000 short tons from the previous month and were up 20,000 short tons compared to April 2020.

Silgan Announces Record First Quarter Earnings and Confirms Full Year Earnings Outlook

Net sales for the first quarter of 2018 were $1.01 billion, an increase of $206.9 million, or 25.7 percent, as compared to $805.4 million in 2017. This increase was the result of the acquisition of the Dispensing Systems operations in April 2017 and higher net sales in each of the businesses. Income before interest and income taxes for the first quarter of 2018 was $92.2 million, an increase of $35.4 million, or 62.3 percent, as compared to $56.8 million for the first quarter of 2017, and margins increased to 9.1 percent from 7.1 percent for the same periods. Click Read More below for additional information.
Back To Top
×Close search
Search